Fertility-Sparing surgery for young women with ovarian endometrioid carcinoma: a multicenteric comparative study using inverse probability of treatment weighting

被引:8
作者
Kajiyama, Hiroaki [1 ,2 ]
Yoshihara, Masato [1 ]
Tamauchi, Satoshi [1 ]
Yoshikawa, Nobuhisa [1 ]
Suzuki, Shiro [1 ]
Kikkawa, Fumitaka [1 ]
机构
[1] Nagoya Univ, Grad Sch Med, Dept Obstet & Gynecol, Nagoya, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Obstet & Gynecol, Tsuruma Cho 65,Showa Ku, Nagoya 4668550, Japan
基金
日本学术振兴会;
关键词
Ovarian endometrioid carcinoma; Fertility -sparing surgery; Oncologic outcome; Propensity score; Inverse probability of treatment weighting; CLEAR-CELL CARCINOMA; REPRODUCTIVE AGE; CANCER; OUTCOMES; LYMPHADENECTOMY; ADENOCARCINOMA; ASSOCIATION; SURVIVAL;
D O I
10.1016/j.eurox.2019.100071
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction: The aim of this study was to evaluate the oncologic outcome of women with stage I ovarian endometrioid carcinoma (EC) who underwent fertility-sparing surgery (FSS). Materials and nethods: Between 1986 and 2017, a total of 3227 patients with epithelial ovarian carcinoma were retrospectively evaluated based on a central pathological review and search of the medical records from multiple institutions. We identified 24 and 54 patients with stage I EC who underwent FSS and conventional radical surgery (CRS), respectively. Inverse probability of treatment weighting (IPTW)- adjusted Kaplan-Meier and Cox regression analyses were employed to compare OS between the two groups. Results: With follow-up of a total of 78 patients, 9 patients (11.5%) developed recurrence. In addition, 5 patients (6.4%) died of the disease. Recurrence was noted in 3 (10.7%) patients in the FSS group and 6 (11.1%) patients in the CRS group. Death was noted in 2 (8.3%) patients in the FSS group and 3 (5.6%) patients in the CRS group. In the original cohort, there was no significant difference in overall survival (OS) or recurrence-free survival (RFS) between the FSS and RS groups {Log-rank: OS (P = 0.630), RFS (P = 0.757)}. In the IPTW-adjusted cohort, the 5-year OS rates were 96.6 and 92.4% in patients with FSS and CRS, respectively (P = 0.319). Furthermore, the 5-year RFS rate was 88.6% for the FSS group and 88.1% for the CRS group (Log-rank: P = 0.556). Conclusions: Young women with stage I EC undergoing FSS showed a relatively satisfactory prognosis, equal to those receiving CRC. (c) 2019 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:7
相关论文
共 33 条
[1]   Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies [J].
Austin, Peter C. ;
Stuart, Elizabeth A. .
STATISTICS IN MEDICINE, 2015, 34 (28) :3661-3679
[2]   Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].
Bray, Freddie ;
Ferlay, Jacques ;
Soerjomataram, Isabelle ;
Siegel, Rebecca L. ;
Torre, Lindsey A. ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2018, 68 (06) :394-424
[3]   Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers [J].
Chan, John K. ;
Teoh, Deanna ;
Hu, Jessica M. ;
Shin, Jacob Y. ;
Osann, Kathryn ;
Kapp, Daniel S. .
GYNECOLOGIC ONCOLOGY, 2008, 109 (03) :370-376
[4]   Pathology and classification of ovarian tumors [J].
Chen, VW ;
Ruiz, B ;
Killeen, JL ;
Coté, TR ;
Wu, XC ;
Correa, CN .
CANCER, 2003, 97 (10) :2631-+
[5]  
Duska LR, 1999, CANCER, V85, P2623, DOI 10.1002/(SICI)1097-0142(19990615)85:12<2623::AID-CNCR19>3.0.CO
[6]  
2-O
[7]   Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study [J].
Eisenkop, SM ;
Friedman, RL ;
Wang, HJ .
GYNECOLOGIC ONCOLOGY, 1998, 69 (02) :103-108
[8]   Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series [J].
Fruscio, R. ;
Corso, S. ;
Ceppi, L. ;
Garavaglia, D. ;
Garbi, A. ;
Floriani, I. ;
Franchi, D. ;
Cantu, M. G. ;
Bonazzi, C. M. ;
Milani, R. ;
Mangioni, C. ;
Colombo, N. .
ANNALS OF ONCOLOGY, 2013, 24 (01) :138-144
[9]   Long-term results of fertility-sparing treatment compared with standard radical surgery for early-stage epithelial ovarian cancer [J].
Fruscio, Robert ;
Ceppi, Lorenzo ;
Corso, Silvia ;
Galli, Francesca ;
Dell'Anna, Tiziana ;
Dell'Orto, Federica ;
Giuliani, Daniela ;
Garbi, Annalisa ;
Chiari, Stefania ;
Mangioni, Costantino ;
Milani, Rodolfo ;
Floriani, Irene ;
Colombo, Nicoletta ;
Bonazzi, Cristina Maria .
BRITISH JOURNAL OF CANCER, 2016, 115 (06) :641-648
[10]   Pathogenetic Pathways in Ovarian Endometrioid Adenocarcinoma A Molecular Study of 29 Cases [J].
Geyer, Julia Turbiner ;
Angeles Lopez-Garcia, Maria ;
Sanchez-Estevez, Carolina ;
Sarrio, David ;
Moreno-Bueno, Gema ;
Franceschetti, Ilaria ;
Palacios, Jose ;
Oliva, Esther .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2009, 33 (08) :1157-1163